Jonathan Said

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by
    Takashi Kumagai
    Departments of Medicine and Pathology, Center of Health of Science, University of California at Los Angeles School of Medicine, Los Angeles, California 90048, USA
    Clin Cancer Res 10:1508-20. 2004
  2. pmc Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy
    Brian Shuch
    Department of Urology, David Geffen School of Medicine at University of California Los Angles, Los Angeles, California 90095 1738, USA
    Cancer 116:616-24. 2010
  3. pmc Aggressive B-cell lymphomas: how many categories do we need?
    Jonathan W Said
    Department of Pathology, David Geffen School of Medicine, University of California Los Angeles, CA 90095, USA
    Mod Pathol 26:S42-56. 2013
  4. ncbi request reprint Immunodeficiency-related Hodgkin lymphoma and its mimics
    Jonathan W Said
    David Geffen School of Medicine at UCLA, Department of Pathology and Laboratory Medicine UCLA Medical Center, Los Angeles, CA 90095, USA
    Adv Anat Pathol 14:189-94. 2007
  5. ncbi request reprint Biomarker discovery in urogenital cancer
    Jonathan Said
    Department of Pathology and Laboratory Medicine and Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Biomarkers 10:S83-6. 2005
  6. ncbi request reprint Kidney pathology: current classification of renal cell carcinoma
    Jonathan W Said
    Department of Pathology and Laboratory Medicine, University of California Los Angeles, CHS 13 226, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA
    Curr Urol Rep 3:25-30. 2002
  7. ncbi request reprint Transformation to aggressive B-cell lymphoma: morphology, immunophenotype, and molecular characteristics
    Jonathan Said
    David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, U S A
    Appl Immunohistochem Mol Morphol 11:199-205. 2003
  8. doi request reprint Diffuse aggressive B-cell lymphomas
    Jonathan Said
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA
    Adv Anat Pathol 16:216-35. 2009
  9. ncbi request reprint Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy
    Allan J Pantuck
    Department of Urology, University of California School of Medicine, Los Angeles, California 90095 1738, USA
    Cancer 97:2995-3002. 2003
  10. pmc Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival
    Chun Chao
    aDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena bDivision of Research, Kaiser Permanente Northern California, Oakland cDepartments of Obstetrics and Gynecology and Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at University of California Los Angeles dDepartment of Epidemiology, UCLA Fielding School of Public Health, Los Angeles eDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles fDepartment of Medicine and San Francisco General Hospital, University of California, San Francisco, San Francisco gLos Angeles Medical Center, Kaiser Permanente Southern California, Los Angeles, California, USA
    AIDS 29:1943-51. 2015

Detail Information

Publications107 found, 100 shown here

  1. ncbi request reprint RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by
    Takashi Kumagai
    Departments of Medicine and Pathology, Center of Health of Science, University of California at Los Angeles School of Medicine, Los Angeles, California 90048, USA
    Clin Cancer Res 10:1508-20. 2004
    ..We, therefore, investigated these effects in vitro and in vivo either alone or in combination with other compounds...
  2. pmc Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy
    Brian Shuch
    Department of Urology, David Geffen School of Medicine at University of California Los Angles, Los Angeles, California 90095 1738, USA
    Cancer 116:616-24. 2010
    ..The patterns of metastases for these tumors were evaluated to determine if sarcomatoid features were retained at metastasis and whether the percentage of sarcomatoid features in the primary tumor influenced spread...
  3. pmc Aggressive B-cell lymphomas: how many categories do we need?
    Jonathan W Said
    Department of Pathology, David Geffen School of Medicine, University of California Los Angeles, CA 90095, USA
    Mod Pathol 26:S42-56. 2013
    ....
  4. ncbi request reprint Immunodeficiency-related Hodgkin lymphoma and its mimics
    Jonathan W Said
    David Geffen School of Medicine at UCLA, Department of Pathology and Laboratory Medicine UCLA Medical Center, Los Angeles, CA 90095, USA
    Adv Anat Pathol 14:189-94. 2007
    ..Also under consideration is the pathogenesis of these disorders with an emphasis on the role of Epstein-Barr virus...
  5. ncbi request reprint Biomarker discovery in urogenital cancer
    Jonathan Said
    Department of Pathology and Laboratory Medicine and Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Biomarkers 10:S83-6. 2005
    ..As with other biomarkers, major questions still to be addressed is the requirement for universal application with uniform scoring and the need for prospective studies in randomized clinical trials...
  6. ncbi request reprint Kidney pathology: current classification of renal cell carcinoma
    Jonathan W Said
    Department of Pathology and Laboratory Medicine, University of California Los Angeles, CHS 13 226, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA
    Curr Urol Rep 3:25-30. 2002
    ..In addition to a description of the pathologic findings, there is a discussion of tumor markers and prognostic indicators. The clinical significance of the classification is discussed, with reference to recent reports...
  7. ncbi request reprint Transformation to aggressive B-cell lymphoma: morphology, immunophenotype, and molecular characteristics
    Jonathan Said
    David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, U S A
    Appl Immunohistochem Mol Morphol 11:199-205. 2003
    ..Specific morphologic patterns of transformation are described for common subtypes of low-grade B-cell lymphoma. The discussion highlights immunophenotypic, molecular, and genetic characteristics of lymphoma transformation...
  8. doi request reprint Diffuse aggressive B-cell lymphomas
    Jonathan Said
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA
    Adv Anat Pathol 16:216-35. 2009
    ....
  9. ncbi request reprint Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy
    Allan J Pantuck
    Department of Urology, University of California School of Medicine, Los Angeles, California 90095 1738, USA
    Cancer 97:2995-3002. 2003
    ..The current study was performed to determine the impact of the presence of retroperitoneal lymphadenopathy on the survival and response to immunotherapy of patients with metastatic renal cell carcinoma (RCC)...
  10. pmc Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival
    Chun Chao
    aDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena bDivision of Research, Kaiser Permanente Northern California, Oakland cDepartments of Obstetrics and Gynecology and Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine at University of California Los Angeles dDepartment of Epidemiology, UCLA Fielding School of Public Health, Los Angeles eDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles fDepartment of Medicine and San Francisco General Hospital, University of California, San Francisco, San Francisco gLos Angeles Medical Center, Kaiser Permanente Southern California, Los Angeles, California, USA
    AIDS 29:1943-51. 2015
    ..Understanding tumor microenvironment and its impact on prognosis of HIV-related lymphomas may provide insight into novel therapeutic strategies...
  11. ncbi request reprint Functional domains of CCN1 (Cyr61) regulate breast cancer progression
    James O'Kelly
    Division of Hematology Oncology, Cedars Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA
    Int J Oncol 33:59-67. 2008
    ....
  12. doi request reprint CD3-positive large B-cell lymphoma
    Jun Wang
    Department of Pathology and Laboratory Medicine, Loma Linda University Medical Center, Loma Linda, CA, USA
    Am J Surg Pathol 33:505-12. 2009
    ..Immunohistochemistry using additional cell lineage specific markers or molecular analysis for antigen receptor gene rearrangements are necessary for correct determination of the cell lineage in such cases...
  13. doi request reprint Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma
    Jeffrey La Rochelle
    Department of Urology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California 90025, USA
    Cancer 116:4696-702. 2010
    ....
  14. ncbi request reprint Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells
    Noriyuki Takai
    Division of Hematology Oncology, Cedars Sinai Medical Center University of California at Los Angeles School of Medicine, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA
    Clin Cancer Res 10:1141-9. 2004
    ..Our purpose was to investigate the antiproliferative effects of the HDACIs [suberoyl anilide bishydroxamine, valproic acid (VPA), trichostatin A, and sodium butyrate] against six endometrial cancer cell lines...
  15. pmc Effect of Dietary Omega-3 Fatty Acids on Tumor-Associated Macrophages and Prostate Cancer Progression
    Pei Liang
    Department of Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California
    Prostate 76:1293-302. 2016
    ..Given the importance of tumor-associated macrophages (TAMs) in carcinogenesis, we hypothesized that a fish oil-based diet will inhibit TAM infiltration and delay the growth of prostate cancer...
  16. pmc Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy
    William J Aronson
    Department of Urology, School of Medicine, University of California Los Angeles, Box 951738, Los Angeles, CA 90095, USA
    Cancer Prev Res (Phila) 4:2062-71. 2011
    ..These results support further studies evaluating reduction of dietary fat with fish oil supplementation on modulating prostate cancer biology...
  17. doi request reprint Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma
    Tobias Klatte
    Department of Urology, David Geffen School of Medicine at UCLA, Center for Health Sciences, Los Angeles, CA 90025 1738, USA
    J Clin Oncol 27:746-53. 2009
    ..We prospectively studied the prognostic impact of cytogenetic abnormalities on a larger cohort of patients having up to 108 months of follow-up...
  18. pmc Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable?
    Brian Shuch
    Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095 1738, USA
    J Urol 182:2164-71. 2009
    ..Patients with sarcomatoid features are known to have poor outcomes. We reviewed the role of surgery in this population to see if these patients could be identified preoperatively...
  19. pmc Epigenetic regulation and molecular characterization of C/EBPalpha in pancreatic cancer cells
    Takashi Kumagai
    Division of Hematology and Oncology, Cedars Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA
    Int J Cancer 124:827-33. 2009
    ....
  20. ncbi request reprint Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma
    John S Lam
    Department of Urology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California 90095 1738, USA
    Cancer 103:2517-25. 2005
    ..The authors investigated the relation of tumor necrosis to other clinicopathologic factors known to be important prognostic indicators for patients with RCC...
  21. doi request reprint Body Mass Index and Survival in a Prospective Randomized Trial of Localized High-Risk Renal Cell Carcinoma
    Nicholas M Donin
    Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, California
    Cancer Epidemiol Biomarkers Prev 25:1326-32. 2016
    ..The relationship between adiposity and renal cell carcinoma is poorly understood. Prior studies have suggested body mass index (BMI) may be associated with indolent disease...
  22. pmc Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral T/NK-cell lymphomas. A North American PTCL study group project
    Eric D Hsi
    Robert J Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH Department of Pathology, University of California Los Angeles, Los Angeles, CA Department of Anatomic Pathology Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN Department of Pathology, Brigham and Women s Hospital, Boston, MA British Columbia Cancer Agency, Vancouver, BC, Canada
    Am J Surg Pathol 38:768-75. 2014
    ..This evidence-based approach to the diagnosis of PTNKCL informs practicing pathologists, clinical trial designers, and policy-makers regarding required ancillary studies. ..
  23. pmc IGFBP-3 nuclear localization predicts human prostate cancer recurrence
    David B Seligson
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 1738, USA
    Horm Cancer 4:12-23. 2013
    ..High nuclear IGFBP-3 is amongst the strongest predictors of cancer recurrence in patients with low-grade prostate cancers and may therefore play an important role in risk stratification...
  24. doi request reprint Immunomodulator agent-related lymphoproliferative disorders
    Robert P Hasserjian
    Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA
    Mod Pathol 22:1532-40. 2009
    ..Further study is warranted to evaluate how these therapies interact with other immunosuppressive agents and the underlying abnormal immune system to enhance the development of lymphomas and atypical lymphoid proliferations...
  25. ncbi request reprint KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma
    Amy Chadburn
    Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
    Am J Surg Pathol 28:1401-16. 2004
    ..These findings strongly suggest that these decidedly rare KSHV-positive solid lymphomas belong to the spectrum of PEL. Therefore, we propose that the KSHV-positive solid lymphomas be designated extra-cavitary PELs...
  26. doi request reprint Programmed death ligand 1 is expressed by non-hodgkin lymphomas and inhibits the activity of tumor-associated T cells
    David J Andorsky
    Division of Hematology and Oncology, Department of Medicine, and Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, California, USA
    Clin Cancer Res 17:4232-44. 2011
    ..PD-L1 is aberrantly expressed on some epithelial malignancies and Hodgkin lymphomas and may prevent effective host antitumor immunity. The role of PD-L1 in non-Hodgkin lymphomas (NHL) is not well characterized...
  27. pmc An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas
    Katrina K Hoyer
    Department of Pathology and Laboratory Medicine, University of California at Los Angeles School of Medicine, Los Angeles, California 90095 1732, USA
    Am J Pathol 164:893-902. 2004
    ..This pattern of expression suggests that aberrantly increased galectin-3 levels in specific B-cell populations may yield a protective advantage during transformation and/or progression of certain B-cell neoplasms...
  28. pmc Effect of a low-fat fish oil diet on proinflammatory eicosanoids and cell-cycle progression score in men undergoing radical prostatectomy
    Colette Galet
    Department of Urology, University of California Los Angeles, Box 951738, Los Angeles, CA 90095 1738
    Cancer Prev Res (Phila) 7:97-104. 2014
    ..Further studies are warranted to determine whether the LFFO diet antiproliferative effects are mediated through the LTB4/BLT1 and 15(S)-HETE pathways...
  29. pmc Positron emission tomography imaging of endometrial cancer using engineered anti-EMP2 antibody fragments
    Maoyong Fu
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Mol Imaging Biol 15:68-78. 2013
    ....
  30. doi request reprint Plasmacytoma-like post-transplant lymphoproliferative disorder seen in pediatric combined liver and intestinal transplant recipients
    Ashley S Plant
    Department of Pediatrics, Division of Hematology Oncology, Los Angeles, California
    Pediatr Blood Cancer 60:E137-9. 2013
    ....
  31. ncbi request reprint Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection
    Allan J Pantuck
    Department of Urology, University of California School of Medicine, Los Angeles, California, USA
    J Urol 169:2076-83. 2003
    ..We better defined the benefits and morbidity of lymph node dissection in patients with localized renal cell carcinoma using the experience of patients treated at our institution...
  32. doi request reprint Intratumoral but not systemic delivery of CpG oligodeoxynucleotide augments the efficacy of anti-CD20 monoclonal antibody therapy against B cell lymphoma
    David J Betting
    Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, CA 90095 1678, USA
    J Immunother 32:622-31. 2009
    ..Future trials combining IT CpG with anti-CD20 antibodies or the antibody-mediated targeting of CpG directly to the sites of B cell lymphoma may thus be warranted...
  33. pmc Global Igfbp1 deletion does not affect prostate cancer development in a c-Myc transgenic mouse model
    Ashley Gray
    Department of Integrative Biology and Physiology, University of California at Los Angeles, Los Angeles, California, USA
    J Endocrinol 211:297-304. 2011
    ..Global Igfbp1 deletion did result in a significant increase in body weight and body fat mass. Further studies are required to understand the underlying mechanisms for these metabolic effects...
  34. pmc Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas
    Tove Olafsen
    Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA
    J Nucl Med 50:1500-8. 2009
    ..To provide more sensitive, tumor-specific PET imaging of NHL, we sought to develop PET agents targeting CD20...
  35. doi request reprint Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study
    Alberto Breda
    Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    BJU Int 105:940-5. 2010
    ..To prospectively determine the accuracy of 14-, 18- and 20-G core needle biopsies to render the appropriate histological diagnosis of solid, enhancing renal masses, using a controlled, ex-vivo biopsy technique...
  36. ncbi request reprint Systemic mastocytosis with plasma cell dyscrasia: report of a case
    Sheeja T Pullarkat
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095, United States
    Leuk Res 32:1160-3. 2008
    ..We also discuss the pathologic interaction between the neoplastic mast cells of SM and the lymphoid/plasma cell malignancy when these two entities coexist...
  37. ncbi request reprint Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines
    Sakura Sakajiri
    Division of Hematology Oncology, Cedars Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048, USA
    Exp Hematol 33:53-61. 2005
    ..In nude mice, SAHA significantly inhibited growth of a mantle cell lymphoma without major toxic side effects. In summary, HDACIs are promising therapeutic agents for human lymphoid cancers...
  38. ncbi request reprint In vivo efficacy of laparoscopic assisted percutaneous renal cryotherapy: evidence based guidelines for the practicing urologist
    Alberto Breda
    Department of Urology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California 90095, USA
    J Urol 179:333-7. 2008
    ..We compared the lesion geometry of 3, 17 gauge cryoneedles to determine the most effective distance and configuration of the cryoneedles in an in vivo porcine kidney model...
  39. doi request reprint Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia
    Sheeja T Pullarkat
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States
    Leuk Res 32:1770-5. 2008
    ..Blast crisis as a presenting manifestation of CML is rare and detecting clonal evolution of acute leukemia by specialized cytogenetic techniques may have important diagnostic and therapeutic implications...
  40. ncbi request reprint Gene expression profile of serial samples of transformed B-cell lymphomas
    Sven de Vos
    Division of Hematology Oncology, Department of Pathology and Laboratory Medicine, UCLA School of Medicine, Los Angeles, California 90095, USA
    Lab Invest 83:271-85. 2003
    ..In summary, this study shows that transformation of FL to DLBCL is associated with a distinct set of differentially expressed genes of potential functional importance...
  41. ncbi request reprint Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV
    Sven de Vos
    Division of Hematology Oncology and the Department of Pathology and Laboratory Medicine, UCLA School of Medicine, Los Angeles, California 90095 7059, USA
    Diagn Mol Pathol 12:35-43. 2003
    ..In summary, our microarray and QRT-PCR analyses identified several candidate genes whose expression increased when comparing normal follicular mantles with MCL and MCLBV, suggesting a potential pathogenic role in the evolution of MCL-BV...
  42. ncbi request reprint An inverse relation between COX-2 and E-cadherin expression correlates with aggressive histologic features in prostate cancer
    Dinesh S Rao
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, UCLA, Los Angeles, CA 90095
    Appl Immunohistochem Mol Morphol 14:375-83. 2006
    ..Furthermore, these results may provide a rational basis for therapeutic intervention and chemoprevention with COX-2 inhibitor therapy in prostate carcinoma...
  43. doi request reprint Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies
    Arie S Belldegrun
    Department of Urology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California 90095 1738, USA
    Cancer 113:2457-63. 2008
    ..The management of renal cell carcinoma (RCC) is evolving toward less extirpative surgery and the use of targeted therapy. The authors set out to provide a benchmark against which emerging therapies should be measured...
  44. ncbi request reprint Cyr61 suppresses growth of human endometrial cancer cells
    Wenwen Chien
    Department of Hematology Oncology, Cedars Sinai Research Institute, UCLA School of Medicine, 110 George Burns Rd, D5065, Los Angeles, CA 90048, USA
    J Biol Chem 279:53087-96. 2004
    ..In summary, endometrial cancer cells have decreased expression of Cyr61 compared with normal endometrium, and this lowered expression may provide the transformed cells a growth advantage over their normal counterpart...
  45. doi request reprint Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells
    Nils H Thoennissen
    Division of Hematology and Oncology, Cedars Sinai Medical Center, University of California Los Angeles School of Medicine, Los Angeles, California 90048, USA
    Cancer Res 69:5876-84. 2009
    ..Further clinical studies are necessary to confirm our findings in patients with pancreatic cancer...
  46. doi request reprint Histopathology of brow fat in thyroid-associated orbitopathy
    Catherine J Hwang
    Jules Stein Eye Institute, UCLA, Los Angeles, California, USA
    Ophthal Plast Reconstr Surg 28:27-9. 2012
    ....
  47. pmc Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death
    Mary C Clark
    Department of Pathology and Laboratory Medicine, University of California Los Angeles School of Medicine, 10833 Le ConteAve, Los Angeles, CA 90095, USA
    Blood 120:4635-44. 2012
    ..These data identify a novel role for cell-surface gal-3 and CD45 in DLBCL survival and suggest novel therapeutic targets to sensitize DLBCL cells to death...
  48. ncbi request reprint Antibody-based profiling of the phosphoinositide 3-kinase pathway in clinical prostate cancer
    George V Thomas
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095, USA
    Clin Cancer Res 10:8351-6. 2004
    ..Prostate cancers also present unique organ-specific challenges, in that tumors are heterogeneous and diagnostic tissue is extremely limited...
  49. ncbi request reprint Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population
    Ken ryu Han
    Department of Urology, School of Medicine, University of California Los Angeles, 90095 1738, USA
    J Urol 170:2221-4. 2003
    ..In this study a previously published clinical outcome algorithm based on 1997 T stage, Fuhrman grade and performance score is validated using an international database...
  50. pmc Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer
    Gabriela B Iwanski
    Division of Hematology and Oncology, Cedars Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048, USA
    Br J Pharmacol 160:998-1007. 2010
    ..Recently, we showed that the triterpenoid cucurbitacin B inhibited tumour growth in pancreatic cancer cells by inhibition of the JAK/STAT pathway, and synergistically increased antiproliferative effects of gemcitabine in vitro...
  51. ncbi request reprint Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis
    Noriyuki Takai
    Division of Hematology Oncology, Cedars Sinai Medical Center University of California Los Angeles School of Medicine, Los Angeles, California 90048, USA
    Cancer 101:2760-70. 2004
    ..Histone deacetylase inhibitors (HDACIs) can inhibit proliferation, stimulate apoptosis, and induce cell cycle arrest in malignant cells...
  52. ncbi request reprint Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy
    Amnon Zisman
    Kimmel Cancer Center, Division of Urologic Oncology, Department of Urology, University of California School of Medicine, Los Angeles, USA
    J Urol 169:909-16. 2003
    ..We outline the biology, prognosis and role of immunotherapy for renal cell carcinoma with gross venous tumor thrombus...
  53. doi request reprint Carbonic anhydrase-IX score is a novel biomarker that predicts recurrence and survival for high-risk, nonmetastatic renal cell carcinoma: Data from the phase III ARISER clinical trial
    Karim Chamie
    Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA Institute of Urologic Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA Electronic address
    Urol Oncol 33:204.e25-33. 2015
    ..To investigate this uncertainty, we quantified the association of CAIX with lymphatic involvement and survival using data from ARISER study (WX-2007-03-HR)--a prospective trial involving subjects with high-risk nonmetastatic ccRCC...
  54. pmc Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis
    Susanne M Henning
    Center for Human Nutrition, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
    J Nutr Biochem 23:1537-42. 2012
    ..Our results suggest that the inhibition of tumor growth is due to GTP-mediated inhibition of oxidative stress and angiogenesis in the LAPC4 xenograft prostate tumor in SCID mice...
  55. pmc Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma
    Chun Chao
    Department of Research and Evaluation, Kaiser Permanente Southern California, 100 S Los Robles Ave, 2nd Floor, Los Angeles, CA 91101, USA
    Clin Cancer Res 18:4702-12. 2012
    ..We investigated the hypothesis that EBV infection is associated with expression of specific B-cell oncogenic markers in HIV-related diffuse large B-cell lymphoma (DLBCL) and examined the prognostic use of detecting EBV infection...
  56. ncbi request reprint Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infection
    David M Menke
    Department of Pathology, Mayo Clinic, Jacksonville, FL 32224, USA
    Am J Clin Pathol 117:268-75. 2002
    ..The lack of vIL-6 expression in CD with HHV-8 genome suggests that human IL-6 rather than vIL-6 may be the principal pathogenic cytokine...
  57. ncbi request reprint Suppression of cell proliferation and signaling transduction by connective tissue growth factor in non-small cell lung cancer cells
    Wenwen Chien
    Division of Hematology Oncology, Cedars Sinai Medical Center, 8700 Beverly Boulevard, D5022, Los Angeles, CA 90048, USA
    Mol Cancer Res 4:591-8. 2006
    ..Our data suggest that CTGF may behave as a secreted tumor suppressor protein in the normal lung, and its expression is suppressed in many NSCLCs...
  58. pmc Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model
    Naoko Kobayashi
    Department of Urology, School of Medicine, University of California, Los Angeles, CA 90095 1738, USA
    Cancer Res 68:3066-73. 2008
    ..We conclude that dietary fat reduction delays transition from mPIN to invasive cancer in this Myc-driven transgenic mouse model, possibly through suppression of the IGF-Akt pathway and decreased proliferation of mPIN epithelial cells...
  59. doi request reprint Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification
    Tobias Klatte
    Department of Urology, University of California Los Angeles, Los Angeles, California, USA
    J Urol 181:1558-64; discussion 1563-4. 2009
    ..We performed the first prospective study of necrosis in clear cell renal cell carcinoma to our knowledge and tested the traditional presence/absence classification vs an alternative extent based classification...
  60. pmc Epigenetic silencing of Stk39 in B-cell lymphoma inhibits apoptosis from genotoxic stress
    Cynthia E Balatoni
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Am J Pathol 175:1653-61. 2009
    ..Taken together, these data indicate that SPAK loss in B-cell lymphomas promotes increased cell survival with DNA damage and provides a potential mechanism for increased resistance to genotoxic stress in cancer...
  61. doi request reprint Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma
    Tobias Klatte
    Department of Urology, University of California at Los Angeles School of Medicine, Los Angeles, California 90095 1738, USA
    Clin Cancer Res 15:1162-9. 2009
    ..The goal of this study was to evaluate immunohistochemical and cytogenetic features and their prognostic value in papillary renal cell carcinoma (PRCC) subtypes...
  62. ncbi request reprint Collecting duct renal cell carcinoma: clinical study of a rare tumor
    Debby Chao
    Department of Urology, Division of Urologic Oncology, University of California School of Medicine Los Angeles, Los Angeles, CA, USA
    J Urol 167:71-4. 2002
    ..The clinical and pathological features of 6 patients with collecting duct carcinoma treated at a single institution are described...
  63. doi request reprint Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy
    Tobias Klatte
    Department of Urology, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Avenue, 66 118 CHS, Box 951738, Los Angeles, CA 90095 1738, USA
    Cancer Epidemiol Biomarkers Prev 18:894-900. 2009
    ..To identify the molecular signature of localized (N0M0) clear cell renal cell carcinoma (RCC) and assess its ability to predict outcome...
  64. doi request reprint Pathobiology and prognosis of chromophobe renal cell carcinoma
    Tobias Klatte
    Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Urol Oncol 26:604-9. 2008
    ..To analyze pathobiology and prognosis of chromophobe renal cell carcinoma (CRCC)...
  65. ncbi request reprint Unclassified renal cell carcinoma: clinical features and prognostic impact of a new histological subtype
    Amnon Zisman
    Department of Biostatistics, University of California Los Angeles School of Medicine, Los Angeles, CA, USA
    J Urol 168:950-5. 2002
    ..We characterized the histopathological features and clinical behavior of unclassified renal cell carcinoma and compared the prognostic outcome in patients with unclassified and conventional (clear cell) renal cell carcinoma...
  66. ncbi request reprint 2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth
    Noriyuki Takai
    Division of Hematology Oncology, Cedars Sinai Medical Center UCLA School of Medicine, Los Angeles, CA 90048, USA
    Cancer 104:2701-8. 2005
    ..HER2 is a ligand-less member of the HER family that functions as the preferred coreceptor for epidermal growth factor receptor (EGFR), HER3, and HER4...
  67. ncbi request reprint TCL1 expression and Epstein-Barr virus status in pediatric Burkitt lymphoma
    Michael A Teitell
    Department of Pathology and Laboratory Medicine, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Am J Clin Pathol 124:569-75. 2005
    ..However, persistent EBV is not essential for increased TCL1 expression, although elevated TCL1 and c-MYC coexpression might cooperate in the development of most pediatric and adult BL cases...
  68. ncbi request reprint Discovery of epigenetically masked tumor suppressor genes in endometrial cancer
    Noriyuki Takai
    Division of Hematology Oncology, Cedars Sinai Medical Center University of California at Los Angeles School of Medicine, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA
    Mol Cancer Res 3:261-9. 2005
    ..Our data suggest that C/ebpalpha and Tig1 function as tumor suppressor proteins in endometrial cancers and that their reexpression may be a therapeutic target...
  69. ncbi request reprint Cystic renal cell carcinoma: biology and clinical behavior
    Ken ryu Han
    UCLA Department of Urology, Los Angeles, CA, USA
    Urol Oncol 22:410-4. 2004
    ..These findings suggest that cRCC patients may benefit from nephron sparing surgery...
  70. ncbi request reprint HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo
    Takayuki Ikezoe
    Division of Hematology Oncology, Cedars Sinai Medical Center and UCLA School of Medicine, Los Angeles, California, USA
    Cancer Res 64:7426-31. 2004
    ..In summary, combination therapy of ritonavir and anticancer drugs holds promise for the treatment of individuals with advanced, drug resistant cancers...
  71. ncbi request reprint Effect of ligands of nuclear hormone receptors on sodium/iodide symporter expression and activity in breast cancer cells
    Sakae Tanosaki
    Division of Hematology Oncology, Department of Medicine, Cedars Sinai Research Institute, University of California Los Angeles School of Medicine, Los Angeles, CA 90048, USA
    Breast Cancer Res Treat 79:335-45. 2003
    ....
  72. ncbi request reprint LABAZ1: A metastatic tumor model for renal cell carcinoma expressing the carbonic anhydrase type 9 tumor antigen
    Amnon Zisman
    Division of Urologic Oncology, Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
    Cancer Res 63:4952-9. 2003
    ..Altogether, LABAZ1 provides a relevant and flexible model to study the biology of cRCC, the role of CA IX in RCC tumorigenesis, progression, and metastasis, and a platform for testing new targeted therapeutic strategies...
  73. pmc Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements
    Rebecca L King
    Department of Laboratory Medicine and Pathology Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN Hematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA Division of Hematopathology, University of Pittsburgh Medical Center, Pittsburgh, PA Department of Pathology and Laboratory Medicine, United Health Services Hospitals, Johnson City Binghamton Department of Pathology and Laboratory Medicine, Centrex Clinical Laboratories, Utica, NY Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL Department of Pathology, Duke University, Durham, NC
    Am J Surg Pathol 40:36-43. 2016
    ..These morphologic findings and our previous outcome data suggest that ALK-positive ALCLs and DUSP22-rearranged ALCLs represent prototypical ALCLs, whereas ALCLs lacking rearrangements of both DUSP22 and ALK require further study. ..
  74. doi request reprint Strong expression of chemokine receptor CCR9 in diffuse large B-cell lymphoma and follicular lymphoma strongly correlates with gastrointestinal involvement
    Winnie Wu
    Department of Pathology, University of California Los Angeles UCLA David Geffen School of Medicine, Los Angeles, CA, 90095 1732, USA
    Hum Pathol 45:1451-8. 2014
    ....
  75. pmc Malignant melanoma with neural differentiation: an exceptional case report and brief review of the pertinent literature
    Albert Su
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA
    Am J Dermatopathol 36:e5-9. 2014
    ..The following article details our exceptional case of melanoma with "malignant neurotization" and presents a discussion of the differential diagnosis and brief review of the pertinent literature...
  76. doi request reprint Mimics of cutaneous lymphoma: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop
    George P Sarantopoulos
    AS 255C, UCLA Medical Center, CHS, 10833 LeConte Ave, Los Angeles, CA 90095, USA
    Am J Clin Pathol 139:536-51. 2013
    ....
  77. doi request reprint Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles County
    Theodoros Kelesidis
    Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    J Med Virol 84:777-85. 2012
    ..9 cases per million persons >15 years of age in LA County. Although EBV-HLH is a rare disease, the incidence in adults in Western countries may be underestimated...
  78. ncbi request reprint Ability of potent vitamin D3 analogs to inhibit growth of prostate cancer cells in vivo
    Vijaya Vegesna
    Cedars Sinai Medical Center UCLA School of Medicine, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA
    Anticancer Res 23:283-9. 2003
    ..We compared in vivo the anti-cancer activity of three potent vitamin D3 analogs and 1,25(OH)2D3 at near to each of their maximal tolerated dose (MTD)...
  79. pmc Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1
    Catherine J Hwang
    Jules Stein Eye Institute, University of California at Los Angeles, Los Angeles, California, USA
    Invest Ophthalmol Vis Sci 50:2262-8. 2009
    ..In the present study the authors investigated the role of CD40 ligation on macrophage chemoattractant protein-1 (MCP-1), IL-6, and IL-8 expression in fibroblasts from patients with TAO...
  80. ncbi request reprint Genetic and molecular genetic studies in the diagnosis of immune-related lymphoproliferative disorders
    Jonathan Said
    Department of Pathology, UCLA School of Medicine and UCLA Center for the Health Sciences, Los Angeles, CA 90095 1732, USA
    Hum Pathol 34:341-5. 2003
  81. ncbi request reprint Clinical and pathological diagnosis of peripheral T-cell lymphoma and emerging treatment options: A case-based discussion
    Jonathan Said
    David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Clin Adv Hematol Oncol 7:S1, S4-13; quiz S15. 2009
    ..In addition, data on emerging therapies for PTCLs will be reviewed with an emphasis on novel and investigational agents...
  82. ncbi request reprint Post-transplant multiple myeloma in a pediatric renal transplant patient
    Wendy Y Tcheng
    Gwynne Hazen Cherry Memorial Laboratories, Division of Pediatric Hematology Oncology, UCLA, Los Angeles, California, USA
    Pediatr Blood Cancer 47:218-23. 2006
    ..In contrast to previously described cases of PTLD-myeloma type, this patient was very young, had a clear association with EBV, and an indolent clinical course...
  83. pmc Association of Ig/BCL6 translocations with germinal center B lymphocytes in human lymphoid tissues: implications for malignant transformation
    Xuwei Yang
    Hart and Louise Lyon Immunology Laboratory, Division of Clinical Immunology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, Los Angeles, CA 90095 1680, USA
    Blood 108:2006-12. 2006
    ..This study shows that Ig/BCL6 translocations occur in germinal center-stage B cells in healthy humans, and that Ig/BCL6 CTs per se are not likely sufficient to cause the malignant transformation in the context of human B cells...
  84. doi request reprint Primary dural marginal zone lymphoma in a woman with inflammatory breast cancer
    Richard G Ancheta
    Division of Hematology Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
    J Clin Oncol 26:326-8. 2008
  85. ncbi request reprint Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells
    Yi Ping Jin
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
    Hum Immunol 65:291-302. 2004
    ..These results suggest that exposure of the graft endothelium to low concentrations of anti-HLA Ab may promote cell survival by transducing signals resulting in upregulation of cell survival genes...
  86. ncbi request reprint Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer
    Ken ryu Han
    Department of Urology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California 90095 1738, USA
    J Urol 171:1117-21. 2004
    ..We investigated the expression and potential clinical usefulness of prostate stem cell antigen (PSCA) in CaP using tissue microarrays...
  87. ncbi request reprint Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma
    Amnon Zisman
    Division of Urologic Oncology, Department of Urology, University of California School of Medicine, Los Angeles, CA 90095 1738, USA
    J Clin Oncol 20:4559-66. 2002
    ..To create a comprehensive algorithm that can predict postoperative renal cell carcinoma (RCC) patient outcomes and response to therapy...
  88. ncbi request reprint Renal cell carcinoma with tumor thrombus: is cytoreductive nephrectomy for advanced disease associated with an increased complication rate?
    Amnon Zisman
    Department of Urology Division of Urologic Oncology, University of California School of Medicine, Los Angeles, California, USA
    J Urol 168:962-7. 2002
    ..We examined whether cytoreductive nephrectomy in patients with venous tumor thrombus and metastatic disease is associated with more complications than in those with thrombus without metastatic disease...
  89. ncbi request reprint TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells
    Sigal Gery
    Division of Hematology Oncology, Cedars Sinai Medical Center, Los Angeles, California, CA 90048, USA
    Oncogene 21:4739-46. 2002
    ....
  90. ncbi request reprint Changing concepts in the management of renal oncocytoma
    Debby H Chao
    Division of Urologic Oncology, Department of Urology, University of California, Los Angeles, School of Medicine, Los Angeles, California 90095 1738, USA
    Urology 59:635-42. 2002
  91. ncbi request reprint Differential diagnosis of hypercalcemia in renal malignancy
    Tobias Klatte
    Department of Urology, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California 90095 1738, USA
    Urology 70:179.e7-8. 2007
    ..The differential diagnosis of hypercalcemia in renal malignancy is presented...
  92. pmc Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression
    Makoto Anzo
    David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Cancer Res 68:3342-9. 2008
    ....
  93. doi request reprint Fuhrman grade provides higher prognostic accuracy than nucleolar grade for papillary renal cell carcinoma
    Tobias Klatte
    Department of Urology, University of California Los Angeles, Los Angeles, California 90025 1738, USA
    J Urol 183:2143-7. 2010
    ..Recent evidence suggests that nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. We tested this hypothesis in an independent large series from a single institution...
  94. ncbi request reprint Small lymphoid proliferations in extranodal locations
    Dinesh S Rao
    Center for Health Sciences, UCLA, Department of Pathology and Laboratory Medicine, 10833 Le Conte Ave, Los Angeles, CA 90095, USA
    Arch Pathol Lab Med 131:383-96. 2007
    ..Differentiation from inflammatory or infectious conditions requires knowledge of specific histologic characteristics of the various entities as well as ancillary techniques...
  95. ncbi request reprint Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis
    Hiroshi Kawabata
    Division of Hematology Immunology, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Blood 105:376-81. 2005
    ..These results suggest that up-regulation of hepcidin expression by inflammatory stimuli is independent of TfR2 and that TfR2 is upstream of hepcidin in the regulatory pathway of body iron homeostasis...
  96. pmc Chemoprevention of prostate cancer with lycopene in the TRAMP model
    Ramdev Konijeti
    Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
    Prostate 70:1547-54. 2010
    ..We hypothesized that tomato paste would have greater chemopreventive effects in transgenic adenocarcinoma of the mouse prostate (TRAMP) mice relative to equivalent lycopene doses provided from lycopene beadlets...
  97. ncbi request reprint Primary extranodal nasal-type natural killer/T-cell lymphoma of the brain: a case report
    Vesna Kaluza
    Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Hum Pathol 37:769-72. 2006
    ..This unusual case highlights an unusual presentation of a rare disease entity and highlights the need for a better understanding of the biology and treatment of T-cell lymphomas...
  98. pmc Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma
    Jean Jacques Patard
    CNRS UMR6061 Genetics and development, IFR 140, University of Rennes 1, Rennes, France
    Int J Cancer 123:395-400. 2008
    ....
  99. ncbi request reprint The effects of intentional cryoablation and radio frequency ablation of renal tissue involving the collecting system in a porcine model
    Nicolette K Janzen
    Department of Urology, University of California Los Angeles School of Medicine, 90095, USA
    J Urol 173:1368-74. 2005
    ..Indications and limitations of the technologies are still evolving. In a porcine model we evaluated the safety and efficacy of cryotherapy and radio frequency ablation (RFA) of cortical and deep renal tissue...
  100. ncbi request reprint Identifying progression-associated genes in adult T-cell leukemia/lymphoma by using oligonucleotide microarrays
    Kunihiro Tsukasaki
    Division of Hematology Oncology, Cedars Sinai Medical Center, UCLA School of Medicine, CA, USA
    Int J Cancer 109:875-81. 2004
    ..These results demonstrated that distinct sets of genes that are known to be critical in cellular transformation and/or activation are up- or down-regulated during the transition to the acute phase of ATL...
  101. ncbi request reprint Allelic loss during progression of follicular lymphoma
    Seisho Takeuchi
    Department of Medicine, Kochi University, Okohcho, Nankoku, Kochi 783 8505, Japan
    Leuk Res 28:567-9. 2004
    ..Genetic changes accumulated in relapsed FL in the absence of histological changes compared to initial diagnosis...